# Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid

> **NCT02361515** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 96 (actual)

## Conditions studied

- Prostatic Adenocarcinoma

## Interventions

- **RADIATION:** Moderate hypofractionated radiotherapy
- **RADIATION:** Stereotactic radiotherapy

## Key facts

- **NCT ID:** NCT02361515
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2022-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02361515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02361515, "Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02361515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*